Tyrosine kinase inhibitors (TKIs) are targeted treatments for various cancers. Skin toxicities are one of the most common nonhematological side-effects of TKIs. We report an imatinib mesylate (IM) induced hyperpigmented acne rosacea (AR) and sunitinib-induced palmar hyperkeratosis in the case with gastrointestinal stromal tumor. AR was arisen due to the discontinuation of IM. To the best of our knowledge, this kind of cutaneous side-effect with IM has not been documented previously.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/1078155210374674 | DOI Listing |
Publication Analysis
Top Keywords
acne rosacea
8
imatinib mesylate
8
gastrointestinal stromal
8
stromal tumor
8
rosacea associated
4
associated imatinib
4
mesylate gastrointestinal
4
tumor patient
4
patient tyrosine
4
tyrosine kinase
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!